Michael Hauzer

Michael Hauzer

Auto-generated profile, based on publicly available information

Michael Hauzer

Department of Family Medicine, Haifa & Western Galilee District, Clalit Health Services Community Division, Haifa, Israel

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 December 2021 in Paediatric and Perinatal Epidemiology
Verified
Journal Article
Closed access
PDF file
Carlos DionicioCarlos Dionicio
Carlos Dionicio
NANeora Alterman
Neora Alterman
RCRonit Calderon‐Margalit
Ronit Calderon‐Margalit
MHMichael Hauzer
Michael Hauzer
IKItai Kloog
Itai Kloog
RRRaanan Raz
Raanan Raz

10 August 2023 in Paediatric and Perinatal Epidemiology
Verified
Journal Article
Open access
NANeora Alterman
Neora Alterman
IYIaroslav Youssim
Iaroslav Youssim
DNDaniel Nevo
Daniel Nevo
RCRonit Calderon‐Margalit
Ronit Calderon‐Margalit
YUYuval
Yuval
RRRaanan Raz
Raanan Raz
Background: Childhood overweight and obesity is a global public health problem. Rapid infant weight gain is predictive of childhood overweight. Studies found that exposure to ambient air pollution is associated with childhood overweight, and have linked prenatal exposure to air pollution with rapid infant weight gain.Objectives: To examine the association between prenatal and postnatal ambient NO2 exposure, a traffic-related marker, with rapid weight gain in infants.Methods: We carried out a population-based historical cohort study using data from the Israeli national network of maternal and child health clinics. The study included 474,136 infants born at term with birthweight = 2500 g in 2011-2019 in central Israel. Weekly averages of NO2 concentration throughout pregnancy (prenatal) and the first 4 weeks of life (postnatal) were assessed using an optimized dispersion model and were linked to geocoded home addresses. We modelled weight gain velocity throughout infancy using the SuperImposition by Translation and Rotation (SITAR) method, a mixed-effects nonlinear model specialized for modelling growth curves, and defined rapid weight gain as the highest velocity tertile. Distributed-lag models were used to assess critical periods of risk and to measure relative risks for rapid weight gain. Adjustments were made for socioeconomic status, population group, subdistrict, month and year of birth, and the alternate exposure period - prenatal or postnatal.Results: The cumulative adjusted relative risk for rapid weight gain of NO2 exposure was 1.02 (95% confidence intereval [CI] 1.00, 1.04) for exposure throughout pregnancy and 1.02 (95% CI 1.01, 1.04) for exposure during the first four postnatal weeks per NO2 interquartile range increase (7.3 ppb). An examination of weekly associations revealed that the critical period of risk for the prenatal exposure was from mid-pregnancy to birth.Conclusions: Prenatal and postnatal exposures to higher concentrations of traffic-related air pollution are each independently associated with rapid infant weight gain, a risk factor for childhood overweight and obesity.

21 December 2018 in Medical Mycology
Verified
Journal Article
Closed access
MHMichael Hauzer
Michael Hauzer
MCMatan J Cohen
Matan J Cohen
IPItzhack Polacheck
Itzhack Polacheck
AMAllon Moses
Allon Moses
MKMaya Korem
Maya Korem
Changes in the interpretive-breakpoints for antifungals against various Candida species have raised the need to examine the significance of the phenomenon of the growth of microcolonies in agar diffusion inhibition zones, which has generally been considered negligible. The objective was to determine the incidence of cases in which microcolonies demonstrate fluconazole resistance according to current interpretive-breakpoints and whether their growth is associated with therapeutic failure. The fluconazole minimum inhibitory concentrations (MICs) of 100 blood culture isolates of Candida were performed by E-test on Roswell Park Memorial Institute (RPMI) agar and examined for the appearance of microcolonies. Fluconazole MICs of microcolonies were then determined over three generations. The significance of the phenomenon of microcolonies was determined according to clinical data retrieved from electronic files. Microcolonies were a common phenomenon among Candida isolates following incubation on RPMI agar, with a higher frequency among C. albicans isolates as compared to non-albicans Candida across generations (57–93% vs 31–93%, respectively) and a similar fluconazole susceptibility rate over three generations. The rate of microcolonies was similar in both patients with successful and unsuccessful outcome (41% vs 42%, respectively). Microcolonies are a common phenomenon. No increase in MIC was demonstrated throughout three generations of microcolony inoculation on RPMI, and no difference in clinical outcome was observed.

1 May 2025 in Israel Journal of Health Policy Research
Verified
Journal Article
Open access
PDF file
RRRaanan Raz
Raanan Raz
Maya NegevMaya Negev
Maya Negev
MHMichael Hauzer
Michael Hauzer
EMEliaz Miller
Eliaz Miller
OPOra Paltiel
Ora Paltiel
MKMeidad Kissinger
Meidad Kissinger
Background: Environmental management in the Israeli health system is driven primarily by safety regulations. Such regulations aim to reduce hazardous exposures to employees, patients, and visitors, as well as some specific aspects of broader environmental toxicity to humans and nature. Most environmental precautions in the system target traditional exposures and do not specifically consider the health system’s own impact on climate change. This article aims to justify incorporating climate change mitigation actions into short- and long-term plans in Israeli health organizations and present a schematic strategic roadmap to do so. Main body: Climate change poses many threats to global health, including risks from severe weather events, changes in vector-borne diseases, increased hazardous air pollutants, food and water shortages, and adverse effects on reproductive health. The most effective effort in climate change mitigation is reducing greenhouse gas emissions to the atmosphere. Ignoring the health sector’s emissions contradicts the ancient medical principle: first, do no harm (primum non-nocere). Furthermore, many climate mitigation methods introduce additional health co-benefits. Special attention and medical considerations are needed to safely reduce emissions from the health sector. This article reviews healthcare’s most common emission sources, including energy consumption, transportation, food, waste, supplies, and the supply chain. An organizational carbon management strategy should include recognizing the problem and committing to action, estimating the organizational carbon footprint, developing and prioritizing alternative interventions, and developing a carbon management plan with measurable short- and intermediate-term goals. Conclusion: Climate mitigation in the health sector is encompassed by the moral obligation of the Israeli healthcare system to do no harm. Performance measures to support GHG emission reductions should be adopted into the existing, successful Israeli programs of quality measures in medicine, both in the community and hospitals. In addition, Israel academic institutions for health and medical education should incorporate sustainable health into their curricula for students of health professions and as part of continuous medical education. Such policy actions will contribute to a healthy health system that supports climate change mitigation while providing health co-benefits to the Israeli population.

11 May 2020 in Journal of Public Health
Verified
Journal Article
Closed access
PDF file
MHMichael Hauzer
Michael Hauzer
LRLisa Rubin
Lisa Rubin
IGItamar Grotto
Itamar Grotto
RCRonit Calderon-Margalit
Ronit Calderon-Margalit

14 June 2024 in Research Square
Verified
Preprint
Open access
PDF file
MHMichael Hauzer
Michael Hauzer
EAEman Abashi
Eman Abashi
MAMordechai Alperin
Mordechai Alperin
Background Proton pump inhibitor (PPI) use has increased, raising concerns about potential long-term side effects such as increased dementia risk in older adults. Elucidating this relationship is critical for informing clinical prescribing practices. Methods This retrospective cohort study analyzed the electronic medical records of Israeli HMO patients aged 50–75 years who were prescribed PPIs. The cumulative purchased PPI dose was calculated for long-term users (upper quartile), occasional users (lower quartile), and one-time users. Dementia diagnoses and medications were compared between groups. Results Over an average follow-up of 8.8 years, long-term PPI users had dementia diagnosis rates of 7.26% and dementia medication rates of 6.26%, compared to combined rates of 4.77% and 3.86%, respectively, in the control groups over 11.6 and 8.9 years. The hazard ratios between long-term users and controls were 1.24 and 1.13, respectively. Conclusions Long-term PPI use was significantly associated with increased dementia incidence. Our findings highlight the need for careful consideration and monitoring of long-term PPI prescribing in older adults. Further research should explore potential mechanisms and confounding factors to elucidate the PPI-dementia relationship and guide appropriate prescribing practices. Health policymakers should consider using long-term PPI prescriptions as a proxy to identify at-risk individuals and offer tailored approaches to reduce the risk of dementia and mortality.